Anti-HIV agents. Merck's integrase inhibitor--short-term efficacy.
D015658:HIV Infections / Q000188:drug therapy*; D019428:HIV Integrase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D009930:Organic Chemicals / Q000009:adverse effects* / Q000627:therapeutic use; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium
D019428:HIV Integrase Inhibitors; D009930:Organic Chemicals; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium